Replies to post #2166 on Biostax Corp (BTAX)

[noreen]

SeeThruEquity gave them a price target of $0.61 about a year ago. This was if "everything goes perfect" over the next year, meaning they would already begin selling, as they did hope to begin selling already, and there has been delays.

I still believe $0.61 is a very reasonable price target after they begin selling in Nigeria.

https://www.accesswire.com/436922/SeeThruEquity-Initiates-Coverage-on-Immune-Therapeutics-Inc-with-a-Price-Target-of-061